Sylviane Muller

USPTO Granted Patents = 14 (Patent Applications = 5)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 27(Granted Patents)

Company Filing History:

10 out of 5,069

Centre National De La Recherche Scientifique

patents

3 out of 23

Pasteur Sanofi Diagnostics

UniversitÉde Strasbourg

Institut National De La Sante Et De La Recherche Medicale

Centre International De Recherche Aux Frontieres De La Chimie

patents

where one patent can have more than one assignee

Years Active: 1995-2021

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11046657 - Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines (2021-06-29),

2. 10213482 - Methods of treating chronic inflammatory diseases (2019-02-26),

3. 9657072 - Modified peptides and their use for treating autoimmune diseases (2017-05-23),

4. 9458212 - Nanoparticles containing a peptide, vectors containing said nanoparticles, and pharmaceutical uses of said nanoparticles and vectors (2016-10-04),

5. 9017673 - Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy (2015-04-28),

6. 8475800 - Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies (2013-07-02),

7. 8173767 - Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV (2012-05-08),

8. 7872098 - Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies (2011-01-18),

9. 7741280 - Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments (2010-06-22),

10. 7364744 - Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV (2008-04-29),

11. 6455244 - Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents (2002-09-24),

12. 5545718 - Synthetic peptides of the conjugate of ubiquitine and H2A histone (1996-08-13),

13. 5427958 - Synthetic peptides of the conjugate of ubiquitine and H2A histone (1995-06-27),

14. 5407833 - Peptides of the SM-D antigen and their use for diagnosis of systemic (1995-04-18),

Title: The Innovative Mind of Sylviane Muller

Introduction: Sylviane Muller, a brilliant inventor hailing from Strasbourg, France, is known for his groundbreaking contributions to the field of science and technology.

Latest Patents: Sylviane Muller holds several patents in the areas of biotechnology and medical research, focusing on novel treatments for autoimmune diseases and cancer.

Career Highlights: With a distinguished career spanning over three decades, Sylviane Muller has held key positions in prestigious research institutions and universities, where he has spearheaded pioneering projects that have reshaped the landscape of modern medicine.

Collaborations: Throughout his career, Sylviane Muller has collaborated with leading scientists, medical professionals, and pharmaceutical companies to bring his innovative ideas to life. His collaborative efforts have resulted in the development of cutting-edge therapies that have the potential to revolutionize the treatment of various diseases.

Conclusion: Sylviane Muller's relentless pursuit of innovation and his unwavering commitment to advancing scientific knowledge have established him as a trailblazer in the field of biotechnology. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of science and technology.

This text is generated by artificial intelligence and may not be accurate.